LGALS3BP was first discovered from two independent research groups as a 90KDa tumor-associated antigen recognized by SP2 monoclonal antibody in CG-5 human breast cancer cells and by L3 monoclonal antibody in Calu-1 human lung cancer cells [6–8]. The gene discussed is LGALS3BP; the disease is lung carcinoma.